News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endo Health Solutions Inc. (ENDP) Pays $193 Million To Settle Labeling Violations


2/24/2014 7:34:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Endo Health Solutions agreed Friday to plead guilty and pay $192.7 million in a criminal and civil settlement related to its promotion of its pain medicine Lidoderm for uses not approved by the Food and Drug Administration. Under the terms of the plea agreement, Endo will pay $171.9 million to resolve claims of “off-label marketing” and a criminal fine of $20.8 million. Pennsylvania share's of settlement is $1.6 million.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES